UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	October 30, 2015 10:00 A.M.

Form:	S-3
CIK: 0001541157 Company Name: Akari Therapeutics Plc File Number: 333-207443